A quality by design strategy to develop curcumin and siRNA co-loaded lipoplexes to target osteoarthritis-related inflammation and oxidative stress.

Ranamalla SR, Tefas L, Porfire A, Licarete E, Parvathaneni RP, Varghese OP, Sesarman A, Focsan M, Tomuta I, Banciu M

DOI: 10.1016/j.ijpharm.2025.126532
Published: 2026 Feb 20
Container: International journal of pharmaceutics
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijpharm.2025.126532,
  title = {A quality by design strategy to develop curcumin and siRNA co-loaded lipoplexes to target osteoarthritis-related inflammation and oxidative stress.},
  author = {Ranamalla SR and Tefas L and Porfire A and Licarete E and Parvathaneni RP and Varghese OP and Sesarman A and Focsan M and Tomuta I and Banciu M},
  year = {2026},
  journal = {International journal of pharmaceutics},
  doi = {10.1016/j.ijpharm.2025.126532},
  url = {https://doi.org/10.1016/j.ijpharm.2025.126532}
}

RIS

TY  - JOUR
TI  - A quality by design strategy to develop curcumin and siRNA co-loaded lipoplexes to target osteoarthritis-related inflammation and oxidative stress.
AU  - Ranamalla SR
AU  - Tefas L
AU  - Porfire A
AU  - Licarete E
AU  - Parvathaneni RP
AU  - Varghese OP
AU  - Sesarman A
AU  - Focsan M
AU  - Tomuta I
AU  - Banciu M
PY  - 2026
JO  - International journal of pharmaceutics
DO  - 10.1016/j.ijpharm.2025.126532
UR  - https://doi.org/10.1016/j.ijpharm.2025.126532
ER  -

APA

SR, R., L, T., A, P., E, L., RP, P., OP, V., A, S., M, F., I, T., & M, B. (2026). A quality by design strategy to develop curcumin and siRNA co-loaded lipoplexes to target osteoarthritis-related inflammation and oxidative stress.. International journal of pharmaceutics. https://doi.org/10.1016/j.ijpharm.2025.126532

Source records

pubmed · retrieved 2026-09-26T07:30:19.150Z